NCT03851692

Brief Summary

The early placement of an intravenous (iv) line in children anesthetized with halothane has been shown safe and acceptable compared with later placement. However, there's not well known with sevoflurane use (2). The aim of the investigator's study is to determine whether one should make iv attempts during the early induction period (at 60seconds) or lately (90 or 120 s) and waiting until the child receives additional sevoflurane inhalation anesthesia

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2016

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2016

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2016

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

October 27, 2018

Completed
4 months until next milestone

First Posted

Study publicly available on registry

February 22, 2019

Completed
Last Updated

February 22, 2019

Status Verified

February 1, 2019

Enrollment Period

5 months

First QC Date

October 27, 2018

Last Update Submit

February 20, 2019

Conditions

Keywords

SevofluraneIntravenous Cannulationanesthesiachild

Outcome Measures

Primary Outcomes (2)

  • Movement on iv placement

    Number of children who presented movement on iv placement

    In the first 5 min after the anesthesic induction with sevoflurane

  • laryngospasm

    The incidence of laryngospasm

    Time From Intravenous Cannulation to patient extubation

Study Arms (2)

60s (group E)

ACTIVE COMPARATOR

Intravenous cannulation was released either 60 s following loss of lid reflex in group E

Other: Intravenous Cannulation (iv placement)

90 or 120 s (groupe L)

ACTIVE COMPARATOR

Intravenous cannulation was released either 90 or 120 s following loss of lid reflex in group L

Other: Intravenous Cannulation (iv placement)

Interventions

The aim of our study is to determine whether one should make intravenous attempts placement during the early induction period (at 60seconds) or lately (90 or 120 s) and waiting until the child receives additional sevoflurane inhalation anesthesia.

60s (group E)90 or 120 s (groupe L)

Eligibility Criteria

Age1 Year - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • ASA I, II
  • Age from 1 to 12 years old
  • Ambulatory surgery under general anesthesia.

You may not qualify if:

  • Age \<1 year or\> 12 years
  • non-ambulatory surgery,
  • contraindication for induction with sevoflurane

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Hasan AK, Sivasankar R, Nair SG, Hasan WU, Latif Z. Optimum time for intravenous cannulation after induction with sevoflurane, oxygen, and nitrous oxide in children without any premedication. Paediatr Anaesth. 2018 Feb;28(2):179-183. doi: 10.1111/pan.13308. Epub 2018 Jan 8.

    PMID: 29316032BACKGROUND
  • Kumar KR, Sinha R, Chandiran R, Pandey RK, Darlong V, Chandralekha. Evaluation of optimum time for intravenous cannulation after sevoflurane induction of anesthesia in different pediatric age groups. J Anaesthesiol Clin Pharmacol. 2017 Jul-Sep;33(3):371-374. doi: 10.4103/joacp.JOACP_58_16.

    PMID: 29109638BACKGROUND

MeSH Terms

Interventions

Drug Implants

Intervention Hierarchy (Ancestors)

Delayed-Action PreparationsDosage FormsPharmaceutical Preparations

Study Officials

  • Manel Ben Ali, MD

    University Hospital of Fattouma Bourguiba Monastir TUNISIA

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Prospective randomized single blinded parallel group controlled study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

October 27, 2018

First Posted

February 22, 2019

Study Start

August 1, 2016

Primary Completion

December 31, 2016

Study Completion

December 31, 2016

Last Updated

February 22, 2019

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share